baber/WOPTO huggingface dataset:
Patent JP-H11511734-A (JP)
IPC: C07D401/10
Filed: 1996-04-19
Abstract: PCT No. PCT/EP96/01649 Sec. 371 Date Dec. 23, 1997 Sec. 102(e) Date Dec. 23, 1997 PCT Filed Apr. 19, 1996 PCT Pub. No. WO96/33191 PCT Pub. Date Oct. 24, 1996The present patent application discloses compounds having the formula or a pharmaceutically acceptable salt thereof or an oxide thereof wherein R3 is wherein A, B and D each is CH, or one or two of A, B and D is N and the others are CH; R11 is phenyl, benzimidazolyl, or monocyclic heteroaryl, all of which may be substituted one or more times with substituents selected from alkyl, alkoxy, halogen, CF3, amino, nitro, cyano, acylamino, acyl, phenyl and monocyclic heteroaryl; one of R6 and R7 is hydrogen and the other is -CR'=NOR'', wherein R' and R'' each independently are hydrogen, alkyl, alkenyl, alkynyl or phenyl. The compounds are useful for the treartment of various central nervous system disorders such as epilepsy and other convulsive disorders, anxiety, sleep disorders and memory disorders.
Patent JP-H11504790-A (JP)
Title: Ａｉｍ設備を含むｓｄｈ多重化装置
IPC: H04Q11/04
Filed: 1997-02-25
Abstract: (57)【要約】
同期デジタル階層多重化装置は、非同期移動モード逆多重化装置を含んで構成される。多重化装置は、特にＡＴＭレート適合と関連し、一端がＡＩＭに接続され他端が更なるＡＩＭに接続される少なくとも一つのデータ伝送路を有する電気通信システムに含まれる。
Patent JP-2000506387-A (JP)
IPC: C12M1/34
Filed: 1997-03-12
Abstract: PCT No. PCT/GB97/00669 Sec. 371 Date Sep. 11, 1998 Sec. 102(e) Date Sep. 11, 1998 PCT Filed Mar. 12, 1997 PCT Pub. No. WO97/33973 PCT Pub. Date Sep. 18, 1997A process of culturing a microorganism in a culture medium in which process the addition of feed medium is controlled by using the production of a by-product as a measure of the culture conditions, characterized in that the by-product is an electrically charged metabolite produced by the microorganism, and in that the production of the metabolite is monitored by measuring the conductance of the culture medium. The metabolite may be acetate and the microorganism may be yeast which is genetically engineered to produce a desired polypeptide.
Patent JP-H11504915-A (JP)
Title: 組織エントラップメント
IPC: A61K9/127
Filed: 1996-05-03
Abstract: (57)【要約】
診断薬または治療薬の皮膚または充実性腫瘍へのデリバリーは、該薬剤を被包化する脂質含有高分子分子構造（例えば、リポソーム）および該高分子構造の外部に結合した親水性部分のタイプおよび量ならびに該高分子構造を形成する種々の脂質または他の疎水性本体の相対的な割合の至適化によって改良される。
Patent JP-2001510500-A (JP)
Title: ハロゲン不含の反応性ポリイソブテンの製造方法
IPC: C08F4/20
Filed: 1998-01-17
Abstract: (57)【要約】
液相でイソブテン又はイソブテン含有炭化水素混合物のカチオン性重合により５０モル％より多い末端の二重結合の含有量を有し、かつ２８０〜１００００ダルトンの平均分子量Ｍ n を有するハロゲン不含の反応性ポリイソブテンの製造方法において、この重合を−３０℃〜＋４０℃の温度で、元素の周期表のＶ副族及びＶＩ副族の元素の１種以上の酸化物からなる不均一重合触媒の存在で又は酸素含有のジルコニウム化合物とは異なる非ゼオライト系の酸化物の担体材料上に元素の周期表のＶ副族及びＶＩ副族の１種以上の元素の酸化物化合物を含有する不均一重合触媒の存在で実施し、その際触媒は工業的に有効量のハロゲンを含有していない。
Patent JP-2001501570-A (JP)
IPC: C04B24/32
Filed: 1997-03-21
Abstract: Substances useful as water reducing and superplasticizer additives for cement compositions are formed by reaction of carboxylic acid polymers with a polyether, preferably a mixture of monofunctional and difunctional polyethers, derived from C2-C4 epoxides wherein partial cleavage of the polyethers and esterification of the polyethers and the cleavage products thereof by the other reactant are achieved. In one embodiment, a sulfonic acid is used to catalyze the reaction of poly(acrylic acid), a monofunctional ethylene oxide-propylene oxide copolymer, and a difunctional poly(propylene glycol), at a temperature in excess of 140  DEG C.
Patent JP-2001516545-A (JP)
Title: 逆フーリエ型のデータ変換
IPC: H03M7/30
Filed: 1998-12-14
Abstract: (57)【要約】
周波数係数(CF)を有する入力データブロック(IDB)を空間係数(CS)を有する出力データブロック(ODB)へ変換する方法において、下記の階程が実施される。ゼロでない各周波数係数(CF)に対して、予め蓄積されたデータ(PSD)を基に空間係数(IB)の個別ブロックが確立される。このようにして得られた空間係数(IB)の個別ブロックは出力データブロック(ODB)を得るために積み上げられる。この方法は、例えば、逆離散コサイン変換のような逆フーリエ型の変換を、比較的少ない計算努力により実行することを可能とする。この方法は、特にビデオ復号への応用に適している。
Patent JP-2000512725-A (JP)
Title: ５又は８ｋＷ冷凍装置及び該装置のための遠心圧縮機
IPC: F25B1/10
Filed: 1996-04-26
Abstract: (57)【要約】
凝縮器、蒸発器、及び冷却器を備えた電気モータ付きの２段遠心圧縮機のアッセンブリを有する８ｋＷ冷凍装置。前記凝縮器の吸入口は、前記圧縮機のアッセンブリの排出口に接続される一方、前記凝縮器の排出口は、第１及び第２の絞り部材を介して、前記蒸発器の吸入口及び前記冷却器に接続される。前記蒸発器の排出口は、前記圧縮機のアッセンブリの吸入口に連結され、前記冷却器の排出口は、前記アッセンブリの第２段の吸入口に連結される。前記冷却器は、冷却スカートを備え、該冷却スカートの空洞が、ステータとハウジングとの間に介在する。本冷凍装置は、分離容器、回収熱交換器、及び熱調整弁を備え、前記熱調整弁は、前記冷却スカートの吸入口における冷媒の圧力及び温度によって制御され、且つ、前記凝縮器の吸入口を前記蒸発器に接続している管の途中に分離容器を直列に取り付けている。前記分離容器は、気相によって冷媒供給ダクトに接続されている。前記熱交換器は、前記冷媒によって、前記凝縮器の排出口を前記蒸発器の吸入口に前記分離容器を介して接続している管に接続されている。前記第２の絞り部材は、前記冷却スカートからの冷媒排出管内の冷媒の圧力及び温度によって調節される熱調整弁である。
Patent JP-2001512980-A (JP)
IPC: A23G9/00
Filed: 1998-02-13
Abstract: An ice confection containing a plurality of inclusions within the ice confection and a process for producing an ice confection containing a plurality of inclusions within the ice confection by automatically distributing the inclusions through a fruit feeder into the ice mix.
Patent JP-2001510323-A (JP)
Title: 分泌蛋白
IPC: C07K14/435
Filed: 1997-04-16
Abstract: (57)【要約】
新規蛋白を開示する。
Patent JP-2002502298-A (JP)
IPC: A61B5/0496
Filed: 1999-01-25
Abstract: Disclosed is an electrode array (i.e., "sensor") and a method for separating near and far-field signals. In one embodiment a horizontal array is used, and in an alternate embodiment a vertical array is used. The electrode array consists of two well-separated pairs of closely spaced electrodes (and a separate ground element). In a typical application of collecting a channel of EEG, "sensing" electrodes are placed in standard locations (e.g., R and Ctr) with a ground electrode placed elsewhere on the head. The voltage measured between the well-separated sensing electrodes is the far-field dominant (i.e., EEG-dominant) channel. Additional electrodes are placed near each of the two sensing electrodes. (The additional electrodes are immediately lateral to the existing electrodes in the horizontal array, and are immediately above the existing electrodes in the vertical array.) The voltages measured between the pairs of closely spaced electrodes are near-field dominant (i.e., EMG/EOG-dominant) channels. The EEG, EMG and EOG signals can be enhanced by uncoupling them by combining information from all channels. The sensor is connected to a monitor via a patient interface cable (PIC). The sensor contains additional circuitry at the connection site that is used by the monitor to identify the presence and type of sensor, and to configure the monitor to invoke the appropriate software that will apply the method of the current invention to collect and uncouple the EEG, EMG and EOG.
Patent JP-2002514379-A (JP)
Title: 電力ケーブルの継手装置
IPC: H02G15/08
Filed: 1998-04-07
Abstract: (57)【要約】
電力ケーブルの継手装置は、円筒状又は円錐形の凹所（４ａ乃至４ｂ）を含み且つその外面の大部分に亙って、収縮可能なスリーブにより加えられる圧力の作用の下、流動しないグリースにより潤滑された少なくとも１つの管状の剛性な支持要素（４）と、該グリースが、タルクで充填され、少なくとも１つの耐圧性添加剤を含むシリコーン又はグリコールを基材としていることと、その長さの大部分に亙り且つその内端にて上記支持要素（４）を把持する冷間収縮可能な予膨張させたスリーブ（５）と、該支持要素（４）を予膨張させたスリーブ（５）に対して固定された状態に保つ解放可能な固定手段とを備えている。該解放可能な固定手段は、支持要素（４）と収縮可能なスリーブ（５）との間に局部的な摩擦領域を形成し、解放されたとき、支持要素の内端付近にてスリーブを局部的に収縮させ、その後、該支持要素が軸方向外方に押し出されるようにするものである。
Patent JP-2001525800-A (JP)
Title: 新規のシステイン誘導体、その製造のための方法及びそれを含む医薬品
IPC: C07D213/40
Filed: 1998-05-06
Abstract: (57)【要約】
マトリックス金属プロテイナーゼ(MMP)に結合して阻害を及ぼす一般式Ｉの化合物であって
 そのシステイン成分が未保護チオール基を含み、そのシステイン成分がＬ−又はＤ−形態にある化合物：（式中、Ａは−CO−、−SO 2 −、−NH−CO−又は−Ｏ−CO−を表わし、Ｒ 1 は水素；１〜15個の炭素原子の直鎖もしくは枝分れした飽和もしくは不飽和アルキル基；ハロゲン、メルカプト、ヒドロキシ、アルコキシ、アミノもしくはニトロにより置換された、又は任意的に１もしくは複数の置換基により置換された炭素環式非芳香族もしくは芳香族環系により置換された、又は任意的に置換された芳香族もしくは非芳香族複素環により置換されたＣ 1 −Ｃ 15 アルキル基、その医薬的に許容される塩、又はその光学活性形態を表わし、Ｒはヒドロキシ；１〜15個の炭素原子の直鎖もしくは枝分れした飽和もしくは不飽和アルキル基；又は任意的に１もしくは複数個の置換基により置換された炭素環式非芳香族もしくは芳香族環系により置換された、又は任意的に置換された芳香族もしくは非芳香族複素環により置換されたＣ 1 −Ｃ 15 アルキル基、その医薬的に許容される塩、又はその光学活性形態を表わす）、その調製のための方法、医薬組成物、及び医薬品におけるその利用。
Patent JP-2001524922-A (JP)
Title: 単独又は混合した金属酸化物又は酸化ケイ素の製造方法
IPC: C01G1/02
Filed: 1998-05-14
Abstract: (57)【要約】
本発明は、１又はそれ以上の有機前駆物質を含む１又はそれ以上の前駆物質のチャージから、単独又は混合した金属酸化物、又は酸化ケイ素をベースとした産物の製造方法に関する、これらの酸化物は、例えばＴｉ，Ａｌ，Ｍｇ，Ｔｈ，Ｓｉ，Ｂａ，Ｂｃ又はＺｒなどが可能である。上記方法は、超臨界圧力よりも低い圧力に超臨界ＣＯ 2 の圧力を減じることによって上記反応媒体から、単独の又は混合した金属酸化物、または酸化ケイ素をベースとした上記産物を上記前駆物質から形成するために、３１から１００℃までの温度と１０ 7 から５ｘ１０ 7 Ｐａの臨界圧力で、超臨界ＣＯ 2 を含む反応媒体と該前駆物質のチャージとを接触させることを含む。
Patent NZ-195992-A (NZ)
Title: 5-halopyrimidines;their 2-sulphides and s-oxides;pharmaceutical compositions
Inventor: BENNECHE T
IPC: C07H17/02
Filed: 1981-01-09
Abstract: Compounds of the formula   <IMAGE> I  (wherein X represents a halogen atom; n is 0, 1 or 2; R1 and R2, which may be the same or different, each represents a hydrogen atom or a carboxyl, esterified carboxyl, amido or mono- or di-C1-4 alkylamido group or a C1-4 alkyl group which may if desired carry a carboxyl or esterified carboxyl group; and R3 represents a C1-32 saturated or unsaturated, straight or branched, cyclic or acyclic aliphatic group or an araliphatic or heterocyclic substituted aliphatic group, a heterocyclic group or an aryl group which groups may if desired carry one or more substituents selected from halogen atoms and oxo, nitro, hydroxy, etherified hydroxy, esterified hydroxy, primary, secondary or tertiary amino, acylamino etherified mercapto or S=O or -SO2 derivatives thereof and esterified phosphonic acid groups) and, where an acidic or basic group is present, physiologically compatible salts thereof have been found to be of use in combating abnormal cell proliferation. The compounds are prepared inter alia by oxidation of the corresponding sulfide, displacement of a leaving atom or group from the 2-position of the pyrimidine by reaction with a sulfinic acid or by ring closure of the pyrimidine ring.
Patent NZ-198552-A (NZ)
Title: Nona-and deca-peptide l.h.r.h.analogues and pharmaceutical compositions
Inventor: NESTOR J J
IPC: C07K7/06
Filed: 1981-10-05
Abstract: Nonapeptide and decapeptide analogs of LHRH which have the formulaand the pharmaceutically acceptable salts thereof, wherein:X is a D-alanyl residue wherein one hydrogen on C-3 is replaced by:a) a carbocyclic aryl-containing radical selected from the group consisting of phenyl substituted with three or more straight chain lower alkyl groups, naphthyl, anthryl, fluorenyl, phenanthryl, biphenylyl and benzhydryl; orb) a saturated carbocyclic radical selected from the group consisting of cyclohexyl substituted with three or more straight chain lower alkyl groups, perhydronaphthyl, perhydrobiphenylyl, perhydro-2,2-diphenylmethyl, and adamantyl; orc) a heterocyclic aryl containing radical selected from the group consisting of radicals represented by the following structural formulas:wherein A" and A' are independently selected from the group consisting of hydrogen, lower alkyl, chlorine, and bromine, and G is selected from the group consisting of oxygen, nitrogen, and sulfur;A is an aminoacyl residue selected from the group consisting of L-pyroglutamyl, D-pyroglutamyl, N-acyl-L-prolyl, N-acyl-D-prolyl, N-acyl-D-tryptophanyl, N-acyl-D-phenylalanyl, N-acyl-D-p-halophenylalanyl, and N-acyl-X wherein X is as defined previously;B is an amino acyl residue selected from the group consisting of D-phenylalanyl, D-p-halophenylalanyl, 2,2-diphenylglycyl, and X wherein X is as defined previously;C is an amino acyl residue selected from the group consisting of L-tryptophanyl, D-tryptophanyl, D-phenylalanyl and X wherein X is as defined above;E is glycinamide or -NH-R<sup>1</sup>, wherein R<sup>1</sup> is lower alkyl, cycloalkyl, fluoro lower alkyl orR<sup>2</sup> is hydrogen or lower alkyl;are disclosed. These compounds are LHRH antagonists.
Patent NZ-207619-A (NZ)
Title: Hydrolysis of lactose in whey
Inventor: OTTOFRICKENSTEIN H
IPC: C12M1/40
Filed: 1984-03-23
Abstract: A process and reactor are disclosed for the continuous treatment of a turbid liquid with a granular treating agent placed in a fixed bed through which the liquid flows. Preferably, the liquid is whey and the treating agent is lactase immobilized on support particles, and treatment involves hydrolysis of lactose in the whey. During treatment, the flow of whey through the fixed bed is periodically interrupted and a flow of cleansing liquid is passed through the fixed bed countercurrent to the flow of whey. The flow of cleansing liquid is under sufficient hydrostatic pressure to press the fixed bed against moving fragmentation devices to separate and fluidize the support particles into a fluidized bed whereby the support particles containing immobilized lactase are cleansed by removing material deposited thereon from the whey.
Patent NZ-235611-A (NZ)
Title: Phenylacetic acid derivatives, preparation and fungicidal composition
Inventor: MUELLER BERND
IPC: A01N37/38
Filed: 1990-10-09
Abstract: Unsaturated phenylacetic acid derivatives of the general formula <IMAGE>  in which   U is =O=CH-OCH3, =N-OCH3, -N-NH-CH3, =CH2, =CH-CH3, =CH-CH2-CH3 or =CH-S-CH3 and Z<1> and Z<2> are hydrogen, halogen, trifluoromethyl, cyanide, NO2 or the optionally substituted radicals alkyl, alkenyl, aryl, alkynyl, alkoxy, aryloxy, arylalkoxy, acyloxy, hetaryl, -CO2R<1>, -CONR<2>R<3>, COR<4> or NR<5>R<6>, it also being possible for Z<1> and Z<2> to form a ring, A is in the meta- or para-position and represents (CH2)n, CH=CH, O-(CH2)n, O-(CH2)n-CO, CH2-O-CO-(CH2)n, CO-O-(CH2)n, O-CO-(CH2)n, O-(CH2)n-CO-O, O-(CH2)n+2-O, CH2-O-(CH2)n, CH2-S-(CH2)n, CH2-NR<7>-(CH2)n, CH(CN)-O-CO-(CH2)n, CH=N-(CH2)n or CH=N-O-(CH2)n,   n embraces the numbers 0 to 20, B is optionally substituted and can denote hydrogen, alkyl, cycloalkyl, aryl or hetaryl, R<1> to R<7> are hydrogen or the optionally substituted radicals alkyl, cycloalkyl, alkenyl, alkynyl, aryl, hetaryl, aralyl or cycloalkylalkyl and the acid addition products and base addition products thereof, and fungicides and insecticides containing these compounds.
Patent NZ-248991-A (NZ)
Title: Pyridinylamino benzisoxazoles or benzothiazoles and medicaments
Inventor: EFFLAND RICHARD CHARLES
IPC: A61P25/28
Filed: 1993-10-19
Abstract: There are disclosed various compounds of the formula below, <CHEM> R1 is hydrogen, loweralkyl, loweralkenyl, loweralkynyl, arylloweralkyl, cycloalkylloweralkyl, loweralkoxyloweralkyl, hydroxyloweralkyl, aminoloweralkyl, mono- or di-loweralkylaminoloweralkyl, formyl, loweralkylcarbonyl, aminoloweralkylcarbonyl, loweralkoxycarbonyl, mono-or di-aryl-substituted loweralkyl, arylcarbonylloweralkyl, aryloxyloweralkyl, or <CHEM>  -X is O or S; W is hydrogen, halogen, hydroxy, loweralkoxy, arylloweralkoxy, nitro, trifluoromethyl or <CHEM> where R3 is hydrogen, loweralkyl or arylloweralkyl, and R4 is loweralkyl or arylloweralkyl; or alternatively the group <CHEM>  as a whole is <CHEM>  R5 being hydrogen, loweralkyl, aryl or arylloweralkyl; and  Z is hydrogen, halogen, loweralkyl, nitro or amino; which are useful as antidepressants.
Patent NZ-250478-A (NZ)
Title: Enzymatic process for the stereoselective preparation of a heterobicyclic alcohol enantiomer and use as an intermediate to prepare flesinoxan
Inventor: BUIZER NICOLAAS
IPC: C07D319/16
Filed: 1993-12-16
Abstract: The invention relates to substantially pure hetero-bicyclic alcohol enantiomers of the formula I, III, and IV <CHEM>       wherein X is O, S, NH, N-(C1-C4)alkyl or CH2; Y1, Y2 and Y3 are each independently hydrogen or substituents selected from halogen, C1-C4 alkyl, C1-C4 alkoxy, C1-C4-haloalkyl, nitro and cyano;   the NO2 substituent is attached to the bicyclic ring system in   the 5- or 7-position; and   the C*-atom has either the R configuration.   The invention also relates to the use of said enantiomers for the preparation of a pharmacologically active piperazine derivative.
Patent NZ-281886-A (NZ)
Title: Basket type beverage can carrier: tab on end walls assists in holding carrier open for loading
Inventor: HARRELSON GLEN RAY
IPC: B65D5/462
Filed: 1995-02-27
Abstract: A basket-style carrier with means for maintaining the carrier open during loading. The carrier includes tabs foldably connected to the end panel sections at one end of the carrier. When the tabs are folded in at substantially right angles to the end panel sections, they engage a vertical support member to prevent the carrier from closing. When the articles being loaded reach the tabs, they fold the tabs up against the inside face of the end panel sections. The articles themselves maintain the carriers open at that point and the tabs are no longer needed for that purpose.
Patent NZ-286575-A (NZ)
Title: Preparation of uv absorbing contact lens by causing reaction between anhydride groups of a uv absorbing agent dispersed in a lens shaped polymer and hydroxy groups of the polymer
Inventor: MOLOCK FRANK M
IPC: G02B1/04
Filed: 1996-05-14
Abstract: Disclosed is a process for producing an ultraviolet radiation absorbing contact lens from a lens shaped polymer having hydroxyl groups pendant therefrom and having dispersed therein a UV absorbing agent substituted with at least one anhydride group which is exposed to basic conditions such that the hydroxyl groups react with the anhydride groups on the UV absorbing agent. As a result the UV absorbing agent becomes fixed to the polymer through the formation of a covalent ester bond.
Patent NZ-307216-A (NZ)
Title: Procedure for preparing a ready-cooked food portion
Inventor: VIRTANEN PEKKA
IPC: A23B4/10
Filed: 1996-05-07
Abstract: PCT No. PCT/FI96/00258 Sec. 371 Date Nov. 7, 1997 Sec. 102(e) Date Nov. 7, 1997 PCT Filed May 7, 1996 PCT Pub. No. WO96/37111 PCT Pub. Date Nov. 28, 1996A method for preparing a food portion where the food portion is frozen to a temperature of at least -15 DEG  C. a first fat containing layer is applied onto the surface of the food portion and the layer frozen as a first gravy layer, and a second layer of a fat-free liquid is applied onto the first layer and the second layer frozen to inhibiting oxidation of the first layer.
Patent NZ-332709-A (NZ)
Title: Automated climate control system for buildings using adaptive self learning algorithms
Inventor: BODMER JAMES
IPC: F24F11/00
Filed: 1997-05-20
Abstract: In order to reduce energy consumption, a process for programmed control of a home and building automation system uses standard programs and sensors 40 for monitoring the presence or persons 12 in each room.  The automation system triggers actuators 52 of installations 24 or groups of installations as needed.  The system uses adaptive self learning algorithms in the controlling software that monitors and stores the behavior of people present in the home or building.  The algorithms adapt themselves to the behavior of the people to optimise the performance of the building automation system.
Patent NZ-333135-A (NZ)
Title: Systems and methods for monitoring for DNA amplification by fluorescence using acceptor fluorophore labeled nucleic acid probe and a donor fluorophore labeled nucleic acid probe which hybridise to adjacent regions of a target sequence
Inventor: WITTWER CARL T
IPC: G01N35/00
Filed: 1997-06-04
Abstract: A method of analyzing a target DNA sequence of a biological sample for DNA sequence polymorphism, heterozygosity or mutations is claimed comprising: amplifying the target sequence by polymerase chain reaction in the presence of two nucleic acid probes that hybridize to adjacent regions of the target sequence and exciting the biological sample with light at a wavelength absorbed by the donor fluorophore and detecting the emission from the biological sample.. The polymerase chain reaction comprises the steps of adding a thermostable polymerase and primers for the target nucleic acid sequence to the biological sample and thermally cycling the biological sample between at least a denaturation temperature and elongation temperature. One of the probes is labeled with an acceptor fluorophore and the other probe is labeled with a donor fluorophore of a fluorescence energy transfer pair such that upon hybridization of the two probes with the target sequence, the donor and acceptor fluorophore are within 0 to 25 nucleotides of one another.
Patent NZ-337123-A (NZ)
Title: Method, use and kit for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
Inventor: MARIN PER
IPC: A61K31/497
Filed: 1998-02-24
Abstract: Described is the use of a cortisol synthesis inhibitor and growth hormone for the manufacture of a medicament for prevention or treatment of conditions related Metabolic Syndrome in a mammal. Administration can be supplemented by a sex hormone selected from testosterone and estrogen. Also disclosed are corresponding pharmaceutical compositions.
Patent NZ-337882-A (NZ)
Title: Floor sander comprising a motor driven cylindrical body including two tubes, one inside the other
Inventor: ROOS ANDERS
IPC: B24B7/18
Filed: 1998-04-20
Abstract: The specification describes rolls (2) with a rubber coating intended for use in grinding machines (1). The rubber layer consists of a number of sector-like units (9), the lower end of each unit (9) being inserted in a groove (3) in the surface of the roll. This avoids the whole layer having to be replaced, it being sufficient instead to replace one or more units (9).
Patent NZ-338084-A (NZ)
Title: Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
Inventor: HEINEGARD DICK
IPC: C07K14/78
Filed: 1998-04-14
Abstract: Use of cartilage oligomeric matrix protein (COMP) or fragments or analogs thereof for the manufacture of a pharmaceutical composition for prevention or treatment of arthritic conditions. Optionally, COMP can be administered in conjunction with collagene II, collagene IX, collagene XI, or aggrecan.
Patent NZ-500545-A (NZ)
Title: Improved multi-layer container and preform
Inventor: SLAT WILLIAM A
IPC: B65D1/02
Filed: 1998-05-11
Abstract: A multi-layer preform (90), includes: a) a plastic inner liner (10), comprised of a cylindrical walled body, which may or may not include a tapered annular shoulder portion, and a cylindrical walled neck portion extending upwardly from the body (88), and b) a molded outer layer (80). Prior to the outer layer being molded over the plastic inner liner, at least a portion of the liner is crystallized by a heat treatment process (84). The molded outer layer may include a means to receive a closure device (86). When the preform is at an acceptable temperature range for orientation, the multi-layer preform can be blow-molded to form a multi-layer container having improved properties.
Patent NZ-504970-A (NZ)
Title: Scissors type platform lift, with biasing spring loaded to maintain constant level as load is removed
Inventor: MOBBERLEY MICHAEL JOHN
IPC: B66F9/00
Filed: 2000-08-24
Abstract: A centrally located spring biases a load platform away from a base interconnected via juxtaposed scissors mechanisms. This provides for maintaining the platform at a reasonably constant level as load is removed.
Patent NZ-509675-A (NZ)
Title: Anti-cariogenic food product containing caseinoglycomacropeptide (CGMP) in hydrolysed form and coagulated casein which is complexed with calcium (with these two compounds being in their active form) and the use of this composition to prevent or treat dental caries or dental plaque
Inventor: PARMANTIER CLAUDE
IPC: A23L1/305
Filed: 1999-07-20
Abstract: The use of rennetted milk which contains both caseinoglycomacropeptide (CGMP) in hydrolysed form and coagulated casein, complexed with calcium, these two compounds being in their active form, to prepare food compositions to prevent or treat dental carries or dental plaque.
Patent NZ-514252-A (NZ)
Title: A substance delivery device comprising a combustible paperboard strip and at least one of a substance toxic to insects and a perfume.
Inventor: RAMAN AROON
IPC: A01N25/10
Filed: 2000-06-29
Abstract: A device for delivering a substance toxic to insects or a perfume is based on a combustible low density paperboard strip.  The paperboard strip can include a flexible backing sheet for supporting the combustible paperboard strip, especially made from paper which has been treated with a flame retardant.  The device can be cut as a coil so that it burns along a helical path.